药物信息为CLOZAPINE TABLETS, USP (Mylan Pharmaceuticals Inc.): HOW SUPPLIED
- DESCRIPTION
- CONTRAINDICATIONS
- DRUG ABUSE AND DEPENDENCE
- HOW SUPPLIED
- Diseases/Conditions Related to CLOZAPINE TABLETS, USP (Mylan Pharmaceuticals Inc.)
- 外部链接相关的CLOZAPINE TABLETS, USP (Mylan Pharmaceuticals Inc.)
Clozapine Tablets USP, 25 mg and 100 mg are available as follows:
The 25 mg tablets are round, peach, scored tablets with C to the left of the score and 7 to the right of the score on one side of the tablet and M on the other side. They are available as follows:
NDC 0378-0825-01bottles of 100 tablets
The 100 mg tablets are round, green, scored tablets with C11 above the score and blank below the score on one side of the tablet and M on the other side. They are available as follows:
NDC 0378-0860-01bottles of 100 tablets
NDC 0378-0860-05bottles of 500 tablets
Store at 20° to 25°C (68° to 77°F). [See USP for Controlled Room Temperature.]
Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
Drug dispensing should not ordinarily exceed a weekly supply. If a patient is eligible for White Blood Cell (WBC) count and Absolute Neutrophil Count (ANC) testing every 2 weeks, then a two-week supply of clozapine can be dispensed. If a patient is eligible for WBC count and ANC testing every 4 weeks, then a four-week supply of clozapine can be dispensed. Dispensing should be contingent upon the WBC count and ANC test results.
- Drug Information Provided by National Library of Medicine (NLM).
